ABIVAX valuation

ABVX · Euronext Paris · EUR

Compare ABIVAX
€63.00Change from previous close: −17.21%Absolute change: −€13.10

Close · November 20, 2026

Valuation

The average price target of 7 analysts is €131.72.

Data as of November 22, 2026

ABIVAX compared with similar companies

ABIVAX's Price/book: 13.7, +165% against the median of a group of 10 similar companies (5.18).

ABIVAX's metrics compared with similar companies
MetricABIVAXMedian25th–75th percentileBand
Price/book13.75.181.90 – 8.46High
Gross margin100.0%68.1%41.2% – 93.2%High
Operating margin-6,270.4%21.8%9.0% – 34.0%Low
Net margin0.0%19.9%5.3% – 27.8%Low
ROE-252.3%12.2%7.9% – 18.4%Low
Debt/equity0.000.020.01 – 0.06Low

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Other metrics

Valuation multiples

Market cap
€5.52B
Enterprise value
€4.63B
P/E (trailing 12 months)
-15.2
Forward P/E
-21.7
Price/sales
1,181.5
EV/EBITDA
-15.9
EV/revenue
991.3

Profitability and growth

ROA
-62.9%
ROIC
-87.5%
Revenue growth (year over year)
-6.8%
Earnings growth (year over year)
93.2%

Financial health

Total cash
€402.38M
Total debt
€1.21M
Current ratio
5.97
Quick ratio
5.79
Altman Z-Score
37.7
Piotroski F-Score
2.00

Dividends

Dividend yield
0.0%

Analysts and estimates

Average price target
€131.72
Median price target
€131.00
High price target
€180.00
Low price target
€70.00
Analysts with a price target
7
Consensus
Buy
Forward EPS
-€2.90
EPS estimate, current year
-€3.53

Shares and trading

Beta
-0.33
Average volume
132.79K
Shares outstanding
87.54M
Float
70.84M
Institutional ownership
53.0%
Insider ownership
4.5%